What Is Angioplasty?

Angioplasty is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries by advancing a balloon-tipped catheter to the site of stenosis and inflating the balloon under pressure to compress atherosclerotic plaque and restore blood flow. The formal clinical name for the procedure when applied to coronary arteries is percutaneous coronary intervention (PCI), though angioplasty encompasses similar techniques applied throughout the peripheral, renal, and cerebral vasculature. It represents the primary non-surgical method for managing arterial obstruction caused by atherosclerosis and thrombosis.

Andreas Gruentzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) in a human patient in Zurich in 1977, establishing the proof of concept for catheter-based arterial dilation. The subsequent four decades have seen the procedure evolve from plain balloon dilation to complex interventions combining drug-eluting stents, intravascular imaging, and physiological assessment tools.

Procedure Mechanics

Angioplasty begins with vascular access, most commonly through the radial artery at the wrist or the femoral artery in the groin, where a sheath is inserted percutaneously using the Seldinger technique. A guidewire is advanced through the sheath and navigated under fluoroscopic guidance across the stenotic segment of the target artery. The balloon catheter is then tracked over the guidewire to the lesion site and inflated to pressures typically between 6 and 20 atmospheres, depending on lesion characteristics and balloon diameter. Inflation compresses and redistributes the plaque material against the vessel wall, enlarging the luminal cross-sectional area. Contrast agent injection before and after inflation confirms the degree of stenosis reduction. According to the StatPearls entry on percutaneous coronary intervention, the procedure typically lasts between 30 minutes and two hours, with patients remaining awake and sedated rather than under general anesthesia.

Stent Technology

Plain balloon angioplasty was limited by a high rate of restenosis, in which the treated segment re-narrowed within months due to elastic recoil of the vessel wall and neointimal hyperplasia. Bare-metal stents (BMS), introduced into clinical practice in the late 1980s, provided a permanent scaffold that prevented elastic recoil but still carried a restenosis rate of roughly 20 to 30 percent within six months due to smooth muscle cell proliferation. Drug-eluting stents (DES), which coat the metallic scaffold with antiproliferative agents such as sirolimus or paclitaxel embedded in a polymer carrier, reduced restenosis rates to below 10 percent by inhibiting neointimal growth at the treated segment. Bioresorbable vascular scaffolds represent a further development, using polymer-based structures that provide temporary support and then dissolve over one to two years, restoring vessel vasomotion. A detailed clinical review is available through the Cleveland Clinic's overview of percutaneous coronary intervention.

Clinical Outcomes and Limitations

The evidence base for coronary angioplasty spans several large randomized trials that established its role relative to coronary artery bypass grafting (CABG) for different patient subsets. For patients with single-vessel disease and stable angina, PCI achieves symptom relief comparable to CABG with shorter recovery times. For patients with multivessel disease, particularly those with diabetes or complex anatomy scored by the SYNTAX score, CABG retains a survival advantage in some subgroups. Angioplasty of peripheral arteries, used in the treatment of symptomatic lower-extremity arterial disease, reduces claudication and is an alternative to surgical bypass for focal lesions. A limitation of all catheter-based interventions is access to the site of obstruction; very calcified, tortuous, or chronically occluded arteries require specialized equipment including atherectomy catheters and laser-based systems. The Heart and Stroke Foundation's patient resource on PCI describes the range of conditions for which the procedure is recommended.

Applications

Angioplasty has applications across a range of cardiovascular and vascular clinical contexts, including:

• Acute myocardial infarction, where primary PCI is the preferred reperfusion strategy within 90 minutes of symptom onset
• Stable coronary artery disease, for symptom relief in lesions causing ischemia
• Renal artery stenosis, to treat hypertension and preserve kidney function
• Peripheral artery disease of the iliac, femoral, and popliteal vessels
• Carotid artery stenosis, as an alternative to surgical endarterectomy in selected patients